Cytodyn Inc (CYDY)

[DonDonDonDon]

They gambled heavily on combining both groups to get the P value they wanted and lost.

The CD10 and CD12 trials weren't meant to get approval. They literally tried every group: mild, moderate, severe, critical. They were just looking where they might have efficacy like throwing spaghetti against the wall and seeing what sticks. They ended up with 24% efficacy on 62 critical patients. Such a disappointment.